T. D. Westfall

发表

Expression and functional role of Rho‐kinase in rat urinary bladder smooth muscle

J. Hieble, E. Hu, Zunxuan Chen, 2003, British journal of pharmacology.

Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.

I. E. Smith, P. Woollard, J. Liddle, 2006, Journal of medicinal chemistry.

Molecular mechanisms of antidiuretic effect of oxytocin.

R. Schrier, S. Falk, D. Brooks, 2008, Journal of the American Society of Nephrology : JASN.

Neuronal release of soluble nucleotidases and their role in neurotransmitter inactivation

C. Kennedy, P. Sneddon, D. Westfall, 1997, nature.

The interaction of diadenosine polyphosphates with P2X‐receptors in the guinea‐pig isolated vas deferens

C. Kennedy, P. Sneddon, J. Bowes, 1997, British journal of pharmacology.

Characterization of neuromedin U effects in canine smooth muscle.

J. Hieble, J. Disa, A. Sulpizio, 2002, Journal of Pharmacology and Experimental Therapeutics.

Modulation of nerve-evoked contractions by β3-adrenoceptor agonism in human and rat isolated urinary bladder.

P. Camparo, S. Palea, H. Botto, 2014, Pharmacological research.

GW427353 (Solabegron), a Novel, Selective β3-Adrenergic Receptor Agonist, Evokes Bladder Relaxation and Increases Micturition Reflex Threshold in the Dog

N. Aiyar, R. Coatney, J. Hieble, 2007, Journal of Pharmacology and Experimental Therapeutics.

Comparison of the effects of β3‐adrenoceptor agonism on urinary bladder function in conscious, anesthetized, and spinal cord injured rats

X. Gamé, S. Palea, P. Rischmann, 2015, Neurourology and urodynamics.

Fenoterol functionally activates the β₃-adrenoceptor in human urinary bladder, comparison with rat and mouse: implications for drug discovery.

P. Camparo, S. Palea, P. Rischmann, 2012, European journal of pharmacology.

Involvement of beta(3)-adrenoceptors in mouse urinary bladder function: role in detrusor muscle relaxation and micturition reflex.

S. Palea, T. Westfall, C. Rouget, 2009, European journal of pharmacology.

Pharmacological techniques for the in vitro study of the vas deferens.

D. Westfall, T. Westfall, T. D. Westfall, 2001, Journal of pharmacological and toxicological methods.

A new method for producing urinary bladder hyperactivity using a non-invasive transient intravesical infusion of acetic acid in conscious rats.

H. Higashiyama, Mine Kinoshita, Hiroshi Kushida, 2008, Journal of pharmacological and toxicological methods.

Characterization of the ATPase released during sympathetic nerve stimulation of the guinea‐pig isolated vas deferens

C. Kennedy, P. Sneddon, D. Westfall, 2000, British journal of pharmacology.

N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part

D. Demarini, D. Brooks, N. Laping, 2008, Journal of Pharmacology and Experimental Therapeutics.

Differential Effects of p38 Mitogen-Activated Protein Kinase and Cyclooxygenase 2 Inhibitors in a Model of Cardiovascular Disease

N. Aiyar, D. Behm, R. Bentley, 2009, Journal of Pharmacology and Experimental Therapeutics.

ATP as a co-transmitter with noradrenaline in sympathetic nerves--function and fate.

C. Kennedy, P. Sneddon, T. Westfall, 2007, Ciba Foundation symposium.

The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.

J. Hieble, T. Westfall, E. Riedel, 2007, European journal of pharmacology.

Enhancement of sympathetic purinergic neurotransmission in the guinea‐pig isolated vas deferens by the novel ecto‐ATPase inhibitor ARL 67156

C. Kennedy, P. Sneddon, T. Westfall, 1996, British journal of pharmacology.

Release of a soluble ATPase from the rabbit isolated vas deferens during nerve stimulation

J. Menzies, C. Kennedy, P. Sneddon, 2000, British journal of pharmacology.

The ecto-ATPase inhibitor ARL 67156 enhances parasympathetic neurotransmission in the guinea-pig urinary bladder.

C. Kennedy, P. Sneddon, T. Westfall, 1997, European journal of pharmacology.

Identification of Atropine- and P2X1 Receptor Antagonist-Resistant, Neurogenic Contractions of the Urinary Bladder

C. Kennedy, T. Westfall, P. N. Tasker, 2007, The Journal of Neuroscience.

The discovery of GSK221149A: a potent and selective oxytocin antagonist.

Michael J Allen, John Liddle, Fabrizio Nerozzi, 2008, Bioorganic & medicinal chemistry letters.

Effect of Endothelin on Bladder Contraction: Potential Role in Bladder Hyperactivity

J. Hieble, D. Brooks, J. Ventre, 2003, Pharmacology.

Modulation of purinergic neurotransmission.

C. Kennedy, P. Sneddon, D. Westfall, 1999, Progress in brain research.

Chapter 2 Modulation of purinergic neurotransmission

C. Kennedy, P. Sneddon, D. Westfall, 1999 .

Behavioral / Systems / Cognitive Identification of Atropine-and P 2 X 1 Receptor Antagonist-Resistant , Neurogenic Contractions of the Urinary Bladder

C. Kennedy, T. Westfall, P. N. Tasker, 2017 .

The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea‐pig isolated vas deferens

C. Kennedy, P. Sneddon, D. Westfall, 2000, British journal of pharmacology.